Groundbreaking Alzheimer’s study findings unveiled

Groundbreaking Alzheimer’s study findings unveiled

Alzheimer’s Prevention: Lifestyle Changes Show Promise in 2‑Year Trial

Key Findings from the Largest Randomized Study

  • Structured program – monthly coaching, BrainHQ brain training, aerobic and strength exercise, and brain‑healthy diet.
  • Unstructured group – quarterly meetings, general encouragement to stay active.
  • After two years, the structured group increased cognitive function by half a standard deviation, moving a typical participant from the 50th to nearly the 70th percentile.
  • The unstructured group also improved, but gains were significantly smaller.

Trial Design and Population

  • 2,111 participants aged 60‑79 at elevated risk due to medical history and family background.
  • Randomized into coached lifestyle intervention or health education control.
  • Intervention period: two years.

Components of the Structured Intervention

  • BrainHQ online training – 15‑20 minutes, three times weekly.
  • Physical exercise – 10‑35 minutes, eight times weekly (aerobic, flexibility, resistance).
  • Brain‑healthy diet – emphasis on greens, whole grains, weekly fish, healthier snacks.
  • Monthly coaching sessions to guide adherence.

Context within Global Research

  • Part of the worldwide FINGER effort; based on the 2015 Finnish FINGER study.
  • Japan’s J‑MINT PRIME Tamba study used BrainHQ Japanese version and reported a 41% gain in global cognition.
  • Consistent with other isolated work showing lifestyle interventions can reduce cognitive decline risk.

Expert Commentary

Dr. Henry Mahncke, CEO of Posit Science states: “Adopting a structured set of brain‑healthy activities – brain training with BrainHQ, better nutrition, and regular exercise – can substantially improve cognitive function and avert inevitable decline.”

Publication Details

  • Journal: The Journal of the American Medical Association (JAMA).
  • Article Title: “Structured vs Self‑Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial.”
  • Funding: Alzheimer’s Association.